ESR1 and breast neoplasm: In addition, RES promoted breast tumor growth and metastasis in immunocompromised mice implanted with low-metastatic ERα(−), ERβ(+) MDA-MB-231, and highly metastatic ER(−) MDA-MB-435 cancer cell lines.